Determination of Theophylline Clearance After Cimetidine Infusion in Critically Ill Patients

Journal of Infusion Nursing

Volumn 26, Issue 4, 2003, Pages 234-238

  Mojtahedzadeh, Mojtaba ^b   Sadray, Sima ^b   Hadjibabaie, Molouk ^a   Fasihi, Mohiodin ^b   Rezaee, Saeed ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CIMETIDINE; THEOPHYLLINE; ANTIULCER AGENT; BRONCHODILATING AGENT; CYTOCHROME P450 1A2;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; ADOLESCENT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; DRUG INTERACTION; DRUG MONITORING; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; BRONCHIAL SPASM; BRONCHODILATOR AGENTS; CIMETIDINE; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A2; DRUG INTERACTIONS; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES; THEOPHYLLINE; TIME FACTORS;

EID: 0042235413     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200307000-00008     Document Type: Article

References (39)

1. Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R. Cimetidine decreases theophylline clearance. Am Rev Res Dis. 1981;123:615-617.
2. Breen KJ, Bury R, Desmond PV, et al. Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther. 1982;31:297-300.
3. Puurunen J, Sotaniemi E, Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol. 1980;18:185-187.
4. Speeg KV, Patwardhen RV, Avant GR, Mitchell MC, Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology. 1982;82:89-96.
5. Desmond PV, Patwardhen R, Parker R, Schenker S, Speeg KV. Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin, and caffeine. Life Sci. 1980;26:1261-1268.
6. Feely J, Pereira L, Guy E, Hockings N. Factors affecting the response to inhibition of drug metabolism by cimetidine-dose response and sensitivity of elderly and induced subjects. Br J Clin Pharmacol. 1984;7:77-81.
7. Powell JR, Donn KH. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications. J Clin Gastroenterol. 1983;5(suppl 1):95-113.
8. Knodell RG, Holtzman JL, Crankshaw DL, Steele NM, Stanley LN. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterol. 1982;82:84-88.
9. Rendic S, Sunjic V, Toso R, Kajfez F, Ruf H-H. Interaction of cimetidine with liver microsomes. Xenobiotica. 1979;9:555-564.
10. Rocci ML Jr, Grasela DM, Fruncillo RJ, Vlasses PH. The effect of single doses of cimetidine on estimated hepatic blood flow. Drug Intell Clin Pharm. 1985;19:831-834.
11. Ostro MJ, Russell JA, Soldin SJ, Mahon WA, Jeejeebhoy KV. Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology. 1985;89:532-537.
12. Roberts RK, Grice J, Wood L, Petroff V, Mcguffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology. 1981;81:19-21.
13. Reitburg DP, Bernhard H, Schentag JJ. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Ann Intern Med. 1981;95:582-585.
14. Schwartz JI, Bachmann KA, Bond LW, Mahajan VK. Impact of cimetidine on the pharmacokinetics of theophylline. Clin Pharm. 1982;1:534-538.
15. DeAngelis C, Walker SE, Bartle WR. Effect of low-dose cimetidine on theophylline metabolism. Clin Pbarm. 1983;2:563-567.
16. Mulkey PM, Murphy JE, Shleifer NH. Steady-state theophylline pharmacokinetics during and after short-term cimetidine administration. Clin Pharm. 1983;2:439-441.
17. Vestal RE, Thummel KE, Musser B, Mercer GD. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. Br J Clin Pharmacol. 1983;15:411-418.
18. Roberts RK, Grice J, McGuffie C. Cimetidine-theophylline interaction in patients with chronic obstructive airways disease. Med Aust. 1984;140:279-280.
19. Hus K, Garton A, Sproule BJ, Tam YK, Legatt D, Herbert FA. The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction. Am Rev Respir Dis. 1984;130:740-743.
20. Dal Negro R, Pomari C, Zoccatelli O, Trevisan F, Carloni C, Turco P. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine. Int J Clin Pharmacol Ther Toxicol. 1984;22:221-226.
21. Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN. Inhibition of theophylline clearance by cimetidine but not ranitidine. Arch Intern Med. 1984;144:434-436.
22. Ghabrial H, Harman PJ, Desmond PV, Mashford ML, Breen KJ. Use of single doses and rapid sampling to detect interactions with cimetidine. Eur J Clin Pharmacol. 1984;27:603-606.
23. Cusack BJ, Dawson GW, Mercer GD, Vestal RE. Cigarette smoking and theophylline metabolism: Effects of cimetidine. Clin Pharmacol Ther. 1985;37:330-336.
24. Cohen IA, Johnson RR, Hyneck ML, Achem SR. Cimetidine-theophylline interaction: Effects of age and cimetidine dose. Ther Drug Monit. 1985;7:426-434.
25. Seaman JJ, Randolph WC, Frank WO, Dickson B, Putterman K, Young MD. Effects of two cimetidine dosage regimens on serum theophylline levels. Postgrad Med. November 1985;(suppl):47-53.
26. Adebayo GI, Coker HAB. Cimetidine inhibition of theophylline elimination: the influence of adult age and the time course. Biopharm Drug Dispos. 1987;8:149-158.
27. Vestal RE, Cusack BJ, Mercer GD, Dawson GW, Park BK. Aging and drug interactions: effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther. 1987;241:488-500.
28. Ambrose PJ, Harralson AF. Lack of effect of cimetidine on theophylline clearance. Drug Intelligence and Clinical Pharmacy. 1981;15:389-390.
29. Hendeles L, Weinberger M. Theophylline: a "state of the art" review. Pharmacother. 1983;3:2-44.
30. Self TH, Heiker GM, Alloway RR, Kelso TM, Abou-shala N. Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 mcg/ml. Pharmacother. 1993;13:590-594.
31. Jenne JW. Reassessing the therapeutic range for theophylline on laboratory report forms: another viewpoint. Pharmacotherapy. 1993;13:595-597.
32. Weinberger MM, Hendeles L. Reassessing the therapeutic range for theophylline: another perspective. Pharmacotherapy. 1993;13:598-601.
33. Tajerzadeh H, Sadray S. High performance liquid chromatographic determination of theophylline in human serum. Med J Islamic Republic Iran. 1999;13:191-194.
34. Rowland M, Tozer TN. Constant-rate regimens. In: Rowland M, Tozer TN, eds. Clinical Pharmacokinetics: Concepts and Applications. 2nd ed. Philadelphia: Lea & Febiger; 1989:63-77.
35. Steinberg KP. Stress-related mucosal disease in the critically ill patients: Risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med. 2002;30(suppl 6):362-364.
36. Cremer KF, Secor JW, Speeg KV. Effect of route of administration on cimetidine's inhibition of drug metabolism. Clin Pharmacol Ther. 1987;41:246.
37. Cremer KF, Secor J, Speeg KV. The effect of route of administration on the cimetidine-theophylline drug interaction. J Clin Pharmacol. 1989;29:451-456.
38. Gutfeld MB, Welage LS, Walawander CA, Harrison N. The influence of intravenous cimetidine dosing regimens on the disposition of theophylline. J Clin Pharmacol. 1989;29(7):665-669.
39. Gaska JA, Tietze KJ, Rocci ML, Vlasses PH. Theophylline pharmacokinetics: effect of continuous versus intermittent cimetidine iv infusion. J Clin Pharmacol. 1991;31:668-672.